Is MS a Buy or a Sell? The Bull and Bear Case (2026)

Last updated July 2026

Short answer

Both cases are real, which is why the question is contested. The bull case for Morgan Stanley (MS) rests on Wealth management as a recurring-revenue engine: Wealth Management generated roughly 50 percent of total firm revenues in fiscal 2025, anchoring profitability with fee income tied to client assets rather than market transactions. The bear case rests on a simultaneous downturn in asset prices and capital-markets activity would pressure both the fee-based wealth revenues and the transaction-dependent Institutional Securities segment at the same time, which is the scenario that most concerns long-term holders. Analysts covering it publish targets from $184.00 to $262.00 against a $205.33 price, so even the professionals disagree by 33% of their own average. We do not give a verdict. What follows is each case at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.

Morgan Stanley is a global financial services firm founded in 1935 and headquartered in New York City, with offices in 42 countries and more than 80,000 employees. It operates through three segments: Institutional Securities (investment banking, equity and fixed-income trading, prime brokerage, and research), Wealth Management (financial-advisor-led brokerage, investment advisory, lending, and banking services for individuals and families), and Investment Management (equity, fixed income, alternatives, and liquidity strategies for institutions and intermediaries). The firm earns revenue through advisory and underwriting fees, trading gains, and, increasingly, recurring asset-based fees tied to the value of client assets across its wealth and investment management platforms. The current Morgan Stanley took its modern shape through the 1997 merger with Dean Witter Discover and a string of subsequent acquisitions, most notably E*TRADE (2020) and Eaton Vance (2021), which dramatically expanded its self-directed brokerage and asset management capabilities. Ted Pick became Chairman and CEO at the start of 2024, succeeding James Gorman, who had led the firm since 2010 and orchestrated its transformation toward fee-based businesses. Under Pick, the integrated-firm strategy emphasizes cross-selling across all three segments and driving client assets toward fee-based relationships to generate more predictable earnings.

The bull case: what would have to be true for $262.00

The most optimistic published target on MS is $262.00, +27.6% from the $205.33 price as of July 2026. Getting there needs the following to work close to its best case, not merely to avoid going wrong.

Wealth management as a recurring-revenue engine

Wealth Management generated roughly 50 percent of total firm revenues in fiscal 2025, anchoring profitability with fee income tied to client assets rather than market transactions. The segment reported a 30 percent pre-tax margin in Q3 2025 and brought in $81 billion of net new assets in the same quarter. As client assets grow and fee-based flows compound, this segment acts as a structural earnings floor.

Capital-markets cycle recovery

Investment banking revenue surged 44 percent year over year in Q3 2025, driven by more completed mergers, more IPOs, and more fixed-income fundraising. Analysts expect continued recovery in advisory and underwriting fees as deal pipelines that were frozen during the rate-hike cycle are finally executed. A sustained M&A and IPO rebound would provide a meaningful uplift to the Institutional Securities segment on top of already-strong equities trading results.

Equities trading franchise momentum

Morgan Stanley's equities desk produced record results in recent quarters, with Q3 2025 equities revenues jumping 35 percent year over year to $4.12 billion, well above analyst estimates, and driven partly by record prime brokerage activity catering to hedge funds. This franchise has consistently ranked among the top two or three globally and benefits from scale, technology investment, and deep client relationships that are difficult for competitors to replicate quickly.

Scale in client assets and capital return

Total client assets across Wealth and Investment Management reached $9.3 trillion at year-end 2025, and the firm holds more than $400 billion in customer deposits. Following the 2026 stress tests, Morgan Stanley raised its quarterly dividend by 15 percent and announced a new $20 billion stock buyback program, signaling confidence in its capital position and its ability to return cash to shareholders while continuing to invest in the business.

The bear case: what would have to be true for $184.00

The most pessimistic published target is $184.00, -10.4% from the current price. That is not a floor and not a forecast; it is roughly what one analyst thinks Morgan Stanley is worth if the risks below bite instead of the drivers above.

A simultaneous downturn in asset prices and capital-markets activity would pressure both the fee-based wealth revenues and the transaction-dependent Institutional Securities segment at the same time, which is the scenario that most concerns long-term holders. Regulatory capital requirements remain an ongoing headwind, with Basel-related rules potentially requiring the firm to hold more capital against trading and lending exposures, constraining returns. Morgan Stanley's stock also carries a beta above 1.0, meaning it tends to move more than the broader market in both directions, so sharp equity-market selloffs can produce outsized drawdowns. Finally, a structural decline in equity underwriting volumes over a prolonged period would disproportionately affect a firm that has historically ranked as a top equity underwriter globally.

The bear case deserves the same attention as the bull case, and usually gets less. If you are holding MS already, the question is not whether these risks exist but whether any of them has moved from possible to actually happening in the reported numbers.

Where analysts land on MS

21 analysts cover MS, with an average target of $236.38 (+15.1% against $205.33) and a split of 11 buy, 12 hold, 2 sell. Bear in mind sell-side ratings skew positive across the whole market, so that split is not a balanced vote. The full target table, the recent rating actions by firm, and how the consensus has shifted are on the MS forecast and price target page.

How is MS valued? (as of 2026-06-27)

Price
$205.33
Market cap
$322.78B
P/E (TTM)
16.59
Forward P/E
15.09
Price / book
3.10
Beta
1.22
52-week range
$136.17 to $232.25

Snapshot for MS as of July 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.

  • Revenue (Full Year 2025): ~$70.6 billion
  • Net Income (Full Year 2025): ~$13.4 billion (approx., based on ~$10.21 EPS on ~1.58B diluted shares)
  • EPS (TTM): ~$11.04
  • P/E Ratio (TTM): ~19-20x
  • Forward P/E: ~17.6x
  • Market Capitalization: ~$334 billion
  • Return on Tangible Common Equity (Full Year 2025): ~21.6%
  • Annual Dividend Per Share: ~$4.00 (dividend yield ~1.9%)

Morgan Stanley's trailing P/E of roughly 19 to 20 times sits modestly above its own 5-year historical average of around 14 to 15 times, reflecting the market's recognition of the firm's successful shift toward more durable, fee-based earnings. The ROTCE of 21.6% for full-year 2025 demonstrates that the integrated-firm model is generating returns well above most peers' cost of equity, though sustaining that level depends on continued strength in both capital markets and wealth inflows. At a forward P/E of approximately 17.6 times, the stock is not priced as a deep-value name, meaning expectations for continued earnings growth are already embedded in the current price.

How do you decide if MS is a buy?

Rather than asking whether MS is a buy in the abstract, it tends to help to answer four questions:

  • Thesis: do you believe the bull case above, and is it still true today?
  • Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
  • Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
  • Overlap: check whether you already hold MS indirectly through an index or sector ETF before adding more.

What would change your mind on MS

Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.

  • Bull case breaks if: Wealth management as a recurring-revenue engine stalls in the reported numbers rather than in the narrative around them.
  • Bear case breaks if: a simultaneous downturn in asset prices and capital-markets activity would pressure both the fee-based wealth revenues and the transaction-dependent Institutional Securities segment at the same time, which is the scenario that most concerns long-term holders fails to materialise over several reporting periods while the drivers keep compounding.
  • Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.

For the full picture, see the MS stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about MS against your real portfolio and see your actual exposure before deciding.

Investing in Morgan Stanley with AI

Connect the broker you already use and ask Walnut's AI how MS fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.

FAQ

Is MS a good stock to buy right now?

+

That depends on which case you find more convincing, and both are on this page. The bull case rests on Wealth management as a recurring-revenue engine, with revenue (full year 2025) at ~$70.6 billion. The bear case rests on a simultaneous downturn in asset prices and capital-markets activity would pressure both the fee-based wealth revenues and the transaction-dependent Institutional Securities segment at the same time, which is the scenario that most concerns long-term holders. Analysts covering it are spread from $184.00 to $262.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Should I sell MS?

+

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. A simultaneous downturn in asset prices and capital-markets activity would pressure both the fee-based wealth revenues and the transaction-dependent Institutional Securities segment at the same time, which is the scenario that most concerns long-term holders. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $184.00, -10.4% from the $205.33 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.

What is the bull case for MS?

+

Wealth management as a recurring-revenue engine. Wealth Management generated roughly 50 percent of total firm revenues in fiscal 2025, anchoring profitability with fee income tied to client assets rather than market transactions. The most optimistic analyst target on MS is $262.00, +27.6% from the $205.33 price. That figure is only reachable if this thesis works close to its best case.

What is the bear case for MS?

+

A simultaneous downturn in asset prices and capital-markets activity would pressure both the fee-based wealth revenues and the transaction-dependent Institutional Securities segment at the same time, which is the scenario that most concerns long-term holders. Regulatory capital requirements remain an ongoing headwind, with Basel-related rules potentially requiring the firm to hold more capital against trading and lending exposures, constraining returns. Morgan Stanley's stock also carries a beta above 1.0, meaning it tends to move more than the broader market in both directions, so sharp equity-market selloffs can produce outsized drawdowns. Finally, a structural decline in equity underwriting volumes over a prolonged period would disproportionately affect a firm that has historically ranked as a top equity underwriter globally. The most pessimistic published target is $184.00, -10.4% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.

What does Morgan Stanley do?

+

Morgan Stanley is a global financial services firm founded in 1935 and headquartered in New York City, with offices in 42 countries and more than 80,000 employees.

What would have to change for MS to stop being worth holding?

+

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Wealth management as a recurring-revenue engine) stalling in the reported numbers rather than in the narrative, the risk above (a simultaneous downturn in asset prices and capital-markets activity would pressure both the fee-based wealth revenues and the transaction-dependent Institutional Securities segment at the same time, which is the scenario that most concerns long-term holders) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

What does Morgan Stanley do?

+

Morgan Stanley is a global financial services firm that operates across three main segments: Institutional Securities (investment banking, sales and trading, and prime brokerage for corporations and institutions), Wealth Management (advisory, brokerage, lending, and banking for individuals and families), and Investment Management (mutual funds, alternatives, and institutional strategies). The firm holds approximately $9.3 trillion in total client assets across its wealth and investment management businesses.

Is MS a good stock to buy right now?

+

Whether MS fits a portfolio depends on individual goals, time horizon, risk tolerance, and existing financial-sector exposure. The firm's fee-based wealth revenues provide more earnings stability than it had a decade ago, and it trades at roughly 19 to 20 times trailing earnings. Investors comfortable with financial-sector cyclicality and a beta above 1.0 tend to view the integrated model as a long-term compounder; others may find the valuation leaves limited margin of safety.

Does MS pay a dividend?

+

Yes. Morgan Stanley pays a quarterly cash dividend. Following the June 2026 stress tests, the firm raised its quarterly dividend by 15 percent. The annualized dividend stands at approximately $4.00 per share, implying a yield of roughly 1.9 percent at recent share prices. The firm also announced a new $20 billion share repurchase program alongside the dividend increase, reflecting its strong capital position.

Walnut is informational, not investment advice, and gives no verdict on MS. Analyst targets referenced here come from a July 2026 pull of published third-party research and change constantly. Verify current figures with your broker before acting on them.

Guides that feature MS

MS is one of the names covered in these guides. Each one puts the stock next to its peers so you can see where it fits rather than judging it alone.

Related stocks

    Is MS a Buy or a Sell? The Bull and Bear Case (2026), Walnut